HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xing, S. Articles by Jhiang, S. M. Search for Related Content PubMed PubMed Citation Articles by Xing, S. Articles by Jhiang, S. M. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 9, 4909-4914, February 27, 1998

Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma Cells

From the Departments of Physiology and Internal Medicine and Ohio State Biochemistry Graduate Program, The Ohio State University, Columbus, Ohio 43210

Gene alterations in the ret proto-oncogene, which encodes a receptor tyrosine kinase, have been found to associate with several human diseases. In this study, we showed that induction of the vgf promoter activity is a good molecular indicator for RET activation in PC12 cells, a rat pheochromocytoma cell line. We demonstrated that all forms of RET oncoprotein, including RET chimeric oncoproteins found in human papillary thyroid carcinomas (RET/PTC) as well as RET oncoproteins found in patients with multiple endocrine neoplasia type 2A and 2B (2A/RET and 2B/RET) can induce vgf promoter activity in PC12 cells. In contrast, a RET mutant found in a patient with Hirschsprung's disease, as well as a RET/PTC1 mutant with deletion of the dimerization domain, failed to induce vgf promoter activity in PC12 cells. We further determined that the signaling events mediated by phosphorylated Tyr²⁹⁴ and phosphorylated Tyr⁴⁵¹ binding sites are essential for RET/PTC1 to induce vgf promoter activity in PC12 cells. We also showed that RET/PTC1, 2A/RET, and 2B/RET induce ELK-, cAMP-responsive element binding protein (CREB), or JUN-mediated gene expression in PC12 cells, and these three signaling events are mediated by phosphorylated Tyr²⁹⁴ and phosphorylated Tyr⁴⁵¹ binding sites in RET/PTC1.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Z.-l. Yuan, Y.-j. Guan, L. Wang, W. Wei, A. B. Kane, and Y. E. Chin Central Role of the Threonine Residue within the p+1 Loop of Receptor Tyrosine Kinase in STAT3 Constitutive Phosphorylation in Metastatic Cancer Cells Mol. Cell. Biol., November 1, 2004; 24(21): 9390 - 9400. [Abstract] [Full Text] [PDF]

				D. K. Marsee, A. Venkateswaran, H. Tao, D. Vadysirisack, Z. Zhang, D. D. Vandre, and S. M. Jhiang Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells J. Biol. Chem., October 15, 2004; 279(42): 43990 - 43997. [Abstract] [Full Text] [PDF]

				S. M. Myers and L. M. Mulligan The RET Receptor Is Linked to Stress Response Pathways Cancer Res., July 1, 2004; 64(13): 4453 - 4463. [Abstract] [Full Text] [PDF]

				V Vasko, M Saji, E Hardy, M Kruhlak, A Larin, V Savchenko, M Miyakawa, O Isozaki, H Murakami, T Tsushima, et al. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer J. Med. Genet., March 1, 2004; 41(3): 161 - 170. [Abstract] [Full Text] [PDF]

				J. Xu, F. Moatamed, J. S. Caldwell, J. R. Walker, Z. Kraiem, K. Taki, G. A. Brent, and J. M. Hershman Enhanced Expression of Nicotinamide N-Methyltransferase in Human Papillary Thyroid Carcinoma Cells J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4990 - 4996. [Abstract] [Full Text] [PDF]

				A. H. Fischer, P. Taysavang, and S. M. Jhiang Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase Am. J. Pathol., September 1, 2003; 163(3): 1091 - 1100. [Abstract] [Full Text] [PDF]

				B. Mograbi, R. Bocciardi, I. Bourget, T. Juhel, D. Farahi-Far, G. Romeo, I. Ceccherini, and B. Rossi The Sensitivity of Activated Cys Ret Mutants to Glial Cell Line-Derived Neurotrophic Factor Is Mandatory To Rescue Neuroectodermic Cells from Apoptosis Mol. Cell. Biol., October 15, 2001; 21(20): 6719 - 6730. [Abstract] [Full Text] [PDF]

				M. D. Ringel, N. Hayre, J. Saito, B. Saunier, F. Schuppert, H. Burch, V. Bernet, K. D. Burman, L. D. Kohn, and M. Saji Overexpression and Overactivation of Akt in Thyroid Carcinoma Cancer Res., August 1, 2001; 61(16): 6105 - 6111. [Abstract] [Full Text] [PDF]

				E. A. Nillni, R. Steinmetz, and O. H. Pescovitz Posttranslational Processing of Progrowth Hormone-Releasing Hormone Endocrinology, December 1, 1999; 140(12): 5817 - 5827. [Abstract] [Full Text]

				S. Qiao, T. Iwashita, T. Furukawa, M. Yamamoto, G. Sobue, and M. Takahashi Differential Effects of Leukocyte Common Antigen-related Protein on Biochemical and Biological Activities of RET-MEN2A and RET-MEN2B Mutant Proteins J. Biol. Chem., March 16, 2001; 276(12): 9460 - 9467. [Abstract] [Full Text] [PDF]